Chemical industry – Page 2
-
Business
Crispr Nobel laureates get another chance to claim ownership in long-running patent dispute
Jennifer Doudna and Emmanualle Charpentier could recoup patent rights to the gene-editing technology, thanks to ruling from US appeal court
-
Research
Polymer membrane separates hydrocarbons, offering alternative to distillation
Microporous membrane enables energy efficient chemical separations
-
Business
Explosion and fire at Chinese chemical plant kills five
Six others missing and 19 injured at Shandong Youdao Chemical
-
Opinion
Ignoring women’s health shouldn’t be an option
Developing therapies for conditions that predominantly affect women is a neglected, but enormous, opportunity
-
Opinion
Women are not just another confounding factor in drug development
Ignoring physiological differences between the sexes is indefensible
-
Business
Trade deals stave off Trump’s tariffs temporarily
Initial agreements with China and UK have paused trade war, but uncertainty reigns
-
Business
US approves natural food dyes while pushing to phase out synthetic colours
Government sets voluntary goal of removing artificial colours by 2027
-
Opinion
Rebuilding pharma supply chains
Multinationals are promising huge US investments, but it’s not all because of Trump’s policies
-
Opinion
Iran port explosion highlights issues of shipping hazardous chemicals
Intersecting regulations and jurisdictions mean rules can be accidentally or deliberately overlooked
-
Business
At least 70 dead in Iran port explosion and fire
More than 1000 people injured after cargo caught fire and exploded
-
Opinion
In search of truth and rules
To codify and predict ever more complex phenomena is one of science’s great drivers
-
Business
Merck KGaA to buy cancer specialist SpringWorks
$3.9 billion deal boosts Merck’s pipeline as it faces patent expiries
-
Business
Gilead settles US HIV drug kickback lawsuit
Firm will pay $202 million to federal and state governments
-
Opinion
Giving companies room to grow
Can shopping centres and offices become urban lab spaces for innovative companies to grow and scale-up?
-
Business
Out of the suburbs: the rise of urban labs
Could empty office blocks and shopping centres provide much-needed space for growing companies?
-
Business
The problem of scale-up in the UK
What’s the point of knowledge generation if we’re not creating high value jobs, asks Chris Kay
-
Business
The hole in the UK chemical industry
Norman Keane thinks ICI’s breakup has left a gap in scale-up knowhow and skills, as well as a lack of facilites
-
Opinion
Polymorphs matter – especially when they might disappear
Disappearing polymorphs offer a fascinating example of the dark arts of crystallisation
-
News
Fears grow over the future of mRNA vaccine research in the US
Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad
-
Business
Acceptable levels of (epi)genetic engineering
Amplifying or silencing genes may be preferable to permanently changing genetic code